Skip to content

Evaluation of the validity of fecal microbiota transplantation in middle and lower digestive tract on ulcerative colitis

Evaluation of the validity of fecal microbiota transplantation in middle and lower digestive tract on ulcerative colitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024676
Enrollment
Unknown
Registered
2019-07-20
Start date
2019-07-20
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

the middle gastrointestinal FMT group :the middle gastrointestinal FMT
the lower gastrointestinal FMT group: the lower gastrointestinal FMT

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) clinical manifestations of continuous or repeated attacks of diarrhea, mucous pus and blood with abdominal pain, tenesmus and other systemic symptoms of different degrees, the course of disease in more than 4 ~ 6 weeks.May have the skin, the mucous membrane, the joint, the eye, the liver gallbladder and so on enteral expression.(2) colonoscopy and mucosal biopsy were consistent with the pathological findings of UC

Exclusion criteria

Exclusion criteria: Rule out acute infective enteritis, amebic bowel disease, intestinal tuberculosis, fungal enteritis, antimicrobial correlation enteritis (including false membranous enteritis), ischemic colitis, radioactive enteritis, acidophilic granulocyte enteritis, allergic purpura, collagenous colitis, irritable white disease, colon polyps, colonic diverticulitis and HIV infection combined colon lesions such as infection and the infection colon lesions.

Design outcomes

Primary

MeasureTime frame
modified Mayo scoring system;intestinal barrier function;

Countries

China

Contacts

Public ContactHe Xingxiang

The First Affiliated Hospital of Guangdong Pharmaceutical University

13724887928@qq.com+86 13724887928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026